Pacific Biosciences of California, Inc.
PACB
$1.32
$0.043.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 4.92% | -16.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.92% | -16.73% | |||
| Cost of Revenue | 10.70% | -41.28% | |||
| Gross Profit | -5.20% | 210.18% | |||
| SG&A Expenses | 7.19% | -12.86% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.85% | -27.96% | |||
| Operating Income | -16.62% | 36.31% | |||
| Income Before Tax | -452.26% | 79.86% | |||
| Income Tax Expenses | -68.48% | -8.91% | |||
| Earnings from Continuing Operations | -440.68% | 79.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -440.68% | 79.50% | |||
| EBIT | -16.62% | 36.31% | |||
| EBITDA | -16.33% | 37.78% | |||
| EPS Basic | -431.37% | 79.73% | |||
| Normalized Basic EPS | -14.96% | 31.70% | |||
| EPS Diluted | -380.00% | 77.56% | |||
| Normalized Diluted EPS | -14.96% | 31.70% | |||
| Average Basic Shares Outstanding | 1.58% | 1.30% | |||
| Average Diluted Shares Outstanding | 1.58% | 1.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||